The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.
Condition:   Charcot Marie Tooth Disease, Type 1 Intervention:   Drug: CLZ-2002 Sponsor:   Cellatoz Therapeutics, Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2023 Category: Research Source Type: clinical trials

Natural History Study for Charcot Marie Tooth Disease
Conditions:   Charcot-Marie-Tooth Disease;   Charcot-Marie-Tooth;   Charcot-Marie-Tooth Disease, Type IA;   Charcot-Marie-Tooth Disease Type 2A;   Charcot-Marie-Tooth Disease Type 2;   Charcot-Marie-Tooth Disease, Type 2C;   Charcot-Marie-Tooth Disease Type 2A2B;   Charcot-Marie-Tooth  Disease Type 2B2;   Charcot-Marie-Tooth Disease Type 2A1;   Charcot-Marie-Tooth Disease Type 4B1;   Charcot-Marie-Tooth Disease, Type IB;   Charcot-Marie-Tooth Disease Type 2B1;   Charcot-Marie-Tooth Disease Type 2U (Diagnosis);   Charcot-Marie-Tooth Disease Type 4A;   Ch arcot-Marie-Tooth...
Source: ClinicalTrials.gov - June 15, 2023 Category: Research Source Type: clinical trials